A5101628023- Neuropeptides and Animal Physiology
- Periodontal Regeneration and Treatments
- Drug Transport and Resistance Mechanisms
- Autoimmune Bullous Skin Diseases
- Blood Coagulation and Thrombosis Mechanisms
- Polyomavirus and related diseases
- Bone Tissue Engineering Materials
- Hemophilia Treatment and Research
- Herpesvirus Infections and Treatments
- dental development and anomalies
- Blood disorders and treatments
- Protease and Inhibitor Mechanisms
- Skin and Cellular Biology Research
- Erythrocyte Function and Pathophysiology
- Silk-based biomaterials and applications
- Bone Metabolism and Diseases
- TGF-β signaling in diseases
- Cytomegalovirus and herpesvirus research
- Cervical Cancer and HPV Research
- Chemical Synthesis and Analysis
- Retinoids in leukemia and cellular processes
- Complement system in diseases
- Pharmacogenetics and Drug Metabolism
- Pharmacological Effects and Toxicity Studies
- Bone and Dental Protein Studies
Dalian Medical University
2023
First Affiliated Hospital of Dalian Medical University
2023
Affiliated Hospital of Jining Medical University
2022-2023
Weatherford College
2022
Jining Medical University
2022
Shandong University
2013-2015
Soochow University
2014
Harbin Medical University
2011-2013
First Affiliated Hospital of Harbin Medical University
2011
Abstract Autoimmune hemolytic anemia (AIHA) therapy may be associated with severe complications such as diabetes, hypertension, obesity, osteoporosis, peptic ulcers, infection, and some other diseases. To reduce those effects, we used low-dose rituximab, bortezomib dexamethasone (LowR-BD regimen) to treat AIHA. The purpose of this study was evaluate the efficacy safety regimen. Seven patients warm AIHA (wAIHA) admitted from March 2020 October were treated LowR-BD regimen: Rituximab 100 mg by...
Vascularization is a crucial challenge in tissue engineering. One solution for this problem to implant scaffolds that contain functional genes promote vascularization by providing angiogenic growth factors via gene delivery carrier. Poly(ethylenimine) (PEI) carrier with high transfection efficiency but cytotoxicity. To solve problem, we utilized Antheraea pernyi silk fibroin (ASF), which has favorable cytocompatibility and biodegradability, RGD sequences negative charge, conjunction PEI, as...
Acquired factor VIII (FVIII) inhibitor induces a bleeding disorder caused by specific antibodies to FVIII. The cause of approximately one fifth cases can be attributed autoimmune disorders, such as pemphigus. Here, we describe case refractory acquired FVIII in patient with primary pemphigus and its successful treatment low-dose rituximab. Coagulation studies revealed prolonged activated partial thromboplastin time, which could not corrected the mixing test. At same activity level was...